Novo Nordisk Just Crashed 15% — Buy the Dip? скачать в хорошем качестве

Novo Nordisk Just Crashed 15% — Buy the Dip?

Novo Nordisk (NVO) is down 15% in premarket after its next-generation obesity drug CagriSema failed to outperform Eli Lilly’s tirzepatide in a head-to-head trial. CagriSema delivered 20.2% mean weight loss after 84 weeks, compared with 23.6% for Lilly’s rival drug - raising concerns about Novo’s competitive edge in the obesity market. In this video, we break down: • What happened in the CagriSema trial • Why the market reacted so aggressively • Ozempic’s first-ever year-over-year revenue decline • Margin compression and slowing growth • 2026 guidance showing potential sales decline • Patent risk around Ozempic (2031–2032) • Whether this 15% drop is an overreaction or structural shift Is Novo Nordisk’s obesity dominance under threat - or is this a long-term buying opportunity? 📊 Stocks discussed: Novo Nordisk (NVO) Eli Lilly (LLY) If you want full valuation models, fair value ranges and margin-of-safety breakdowns, join my free weekly newsletter here: https://www.dividendtalks.com/subscribe 🔥 Dividend Talks Exclusive Resources & Bonuses: 📩 Core Free Resources FREE Weekly Newsletter – Stay on top of dividend investing trends: 👉 Subscribe now - https://www.dividendtalks.com/subscribe Stock Valuation Model – Make smarter investment decisions: 👉 Get it here - https://www.buymeacoffee.com/dividend... Join the Community (Discord) – Connect with investors: 👉 Click here -   / dividendtalks   💰 Free Money / Bonuses FREE Shares (up to £100) – Trading212 – Claim yours today: 👉 Sign up here - https://www.trading212.com/invite/Gux... 🔍 Premium Investing Tools (Discounts) $30 OFF Seeking Alpha Premium – Claim here https://www.sahg6dtr.com/29N4DP9/R74QP/ 15% OFF Fiscal AI – Get it here https://fiscal.ai/dividendtalks/?via=... 50% OFF TipRanks – Grab the deal https://tipranks.sjv.io/4GXjPn ☕ Support & Follow Support the channel – Buy Me a Coffee: 👉 Click here https://www.buymeacoffee.com/DIVIDEND... Become a Member – Unlock Perks: 👉 Join here    / @dividendtalks   Follow me on X (Twitter): 👉 www.x.com/DividendTalks I am not a financial advisor or licensed professional. Nothing I say or produce on YouTube or anywhere else, should be considered as advice. All content is for educational purposes only. I am not responsible for any financial losses or gains. Invest and trade at your own risk.